Neurocrine Biosciences Inc
F:NB3
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Neurocrine Biosciences Inc
F:NB3
|
US |
|
Platinum Asset Management Ltd
OTC:PTMGF
|
AU |
|
Shanghai Zhangjiang Hi-Tech Park Development Co Ltd
SSE:600895
|
CN |
|
F
|
Fresh Del Monte Produce Inc
F:FDM
|
US |
|
Electronic Arts Inc
NASDAQ:EA
|
US |
|
W
|
Weichai Power Co Ltd
XMUN:WI4
|
CN |
|
A
|
AG Mortgage Investment Trust Inc
F:8AGA
|
US |
|
Silk Laser Australia Ltd
F:7JS
|
AU |
|
D
|
Dupont De Nemours Inc
LSE:0A6B
|
US |
|
Agora Inc
NASDAQ:API
|
CN |
|
D
|
De La Rue PLC
SWB:DL1C
|
UK |
|
E
|
EVN AG
SWB:EVN
|
AT |
|
S
|
Sovereign Metals Ltd
F:SVM
|
AU |
|
CVB Financial Corp
NASDAQ:CVBF
|
US |
Bankruptcy Probability
Neurocrine Biosciences Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Neurocrine Biosciences Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Neurocrine Biosciences Inc
NASDAQ:NBIX
|
17.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
449.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
197.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
166.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
123.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
71.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
46.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Neurocrine Biosciences Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Neurocrine Biosciences Inc has no debt.
You can find a full breakdown on its Balance Sheet.
